Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In Vivo ectopic expression of OVOL2 and HNF1A in the context of PDA

ABSTRACT: We tested whether ectopic expression of OVOL2 and HNF1 either individually or in combination—the gene pairs inducing the most efficient MOS → GLS transdifferentiation in vitro—could recapitulate MOS → GLS cell state transdifferentiation in vivo

ORGANISM(S): Homo sapiens

PROVIDER: GSE268388 | GEO | 2026/01/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

In Vivo ectopic expression of OVOL2 and HNF1A in the context of PDA

Project description:In Vivo ectopic expression of OVOL2 and HNF1A in the context of PDA

| PRJNA1117001 | ENA

Sequencing data of six PDA cell lines.

Project description:The aim of this study is the classification of PDA cell lines according to the activity of the GLS and MOS MRs

2026-01-16 | GSE159918 | GEO

In vitro arrayed OVOL2 overexpression in PDA Cell Lines (bulk RNA-Seq)

Project description:In this assay OVOL2 was overexpressed in 3 Morphogenic PDA cell lines to investigate its ability to repgram cells toward the Lineage subtype.

2026-01-16 | GSE280160 | GEO

Identification of Ovol2 binding regions in HC11 cells

Project description:Epithelial cells possess remarkable plasticity, having the ability to become mesenchymal cells through alterations in adhesion and motility (epithelial-to-mesenchymal transition or EMT). Recent studies suggest that EMT endows differentiated epithelial cells with stem cell traits, posing the interesting question of how epithelial plasticity is properly restricted to ensure epithelial differentiation during tissue morphogenesis. Here we identify zinc-finger transcription factor Ovol2 as a key suppressor of EMT of mammary epithelial cells. Epithelia-specific deletion of Ovol2 completely arrests mammary ductal morphogenesis, and depletes epithelial stem/progenitor cell reservoirs. Further, Ovol2-deficient epithelial cells undergo EMT in vivo to become non-epithelial cell types, and that Ovol2 directly represses key EMT inducers such as Zeb1 and regulates stem/progenitor cell responsiveness to TGF-beta. We also provide evidence for a suppressive role of Ovol2 in breast cancer progression. Our findings underscore the critical importance of exquisitely regulating epithelial plasticity to balance stemness with epithelial differentiation in development and cancer. We report ChIPseq data illustrating Ovol2 genome-wide targets in mouse mammary epithelial cells, suggesting that Ovol2 regulates a plethora of genes associated with the EMT process. Immunoprecipitated samples from HC11 mouse mammary epithelial cells with antibodies against Ovol2 and control IgG respectively were used for ChIP-seq experiments.

2014-03-19 | E-GEOD-53925 | biostudies-arrayexpress

Identification of Ovol2 binding regions in HC11 cells

2014-03-19 | GSE53925 | GEO

The investigation of OVOL2 regulated gene

Project description:To investigate the OVOL2-regulated gene with MCF7 wild-type and knock-out cells.

2021-12-07 | GSE189947 | GEO

Pooled TFs overexpression assay (single-cell RNAseq)

Project description:The aim of this study is to investigate the effect of the combinatorial overexpression of the top GLS MRs in a MOS cell line (at single-cell level).

2026-01-16 | GSE159921 | GEO

Gene expression analysis of Ovol2-deficent newborn keratinocytes

Project description:We report the differential gene expression differences between control and Ovol2-deficent newborn keratinocytes

2018-11-06 | GSE118915 | GEO

Expression data from isolated terminal end buds in mammary glands with or without Ovol2 deletion

Project description:Epithelial cells possess remarkable plasticity, having the ability to become mesenchymal cells through alterations in adhesion and motility (epithelial-to-mesenchymal transition or EMT). Recent studies suggest that EMT endows differentiated epithelial cells with stem cell traits, posing the interesting question of how epithelial plasticity is properly restricted to ensure epithelial differentiation during tissue morphogenesis. Here we identify zinc-finger transcription factor Ovol2 as a key suppressor of EMT of mammary epithelial cells. Epithelia-specific deletion of Ovol2 completely arrests mammary ductal morphogenesis, and depletes epithelial stem/progenitor cell reservoirs. Further, Ovol2-deficient epithelial cells undergo EMT in vivo to become non-epithelial cell types, and that Ovol2 directly represses key EMT inducers such as Zeb1 and regulates stem/progenitor cell responsiveness to TGF-beta. We also provide evidence for a suppressive role of Ovol2 in breast cancer progression. Our findings underscore the critical importance of exquisitely regulating epithelial plasticity to balance stemness with epithelial differentiation in development and cancer. TEBs from control and conditional Ovol2-knockout mammary glands were physically isolated for RNA extraction and hybridization on Affymetrix microarrays. In order to identify primary changes, we analyzed TEBs from 24-25-day-old mice, when morphological differences between control and Ovol2 SSKO were still minimal.

2014-03-19 | E-GEOD-53923 | biostudies-arrayexpress

In vitro arrayed OVOL2 overexpression in PDA Cell Lines (bulk RNA-Seq)

Project description:In vitro arrayed OVOL2 overexpression in PDA Cell Lines (bulk RNA-Seq)

| PRJNA1176580 | ENA